These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
272 related items for PubMed ID: 23983431
21. Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment. Rigter LS, Snaebjornsson P, Rosenberg EH, Atmodimedjo PN, Aleman BM, Ten Hoeve J, Geurts-Giele WR, PALGA group, van Ravesteyn TW, Hoeksel J, Meijer GA, Te Riele H, van Leeuwen FE, Dinjens WN, van Leerdam ME. Gut; 2018 Mar; 67(3):447-455. PubMed ID: 29439113 [Abstract] [Full Text] [Related]
22. The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms. Borie C, Colas C, Dartigues P, Lazure T, Rince P, Buhard O, Folliot P, Chalastanis A, Muleris M, Hamelin R, Mercier D, Oliveira C, Seruca R, Chadburn A, Leblond V, Barete S, Gaïdano G, Martin A, Gaulard P, Fléjou JF, Raphael M, Duval A. Int J Cancer; 2009 Nov 15; 125(10):2360-6. PubMed ID: 19551857 [Abstract] [Full Text] [Related]
23. Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel. Vilkin A, Niv Y, Nagasaka T, Morgenstern S, Levi Z, Fireman Z, Fuerst F, Goel A, Boland CR. Cancer; 2009 Feb 15; 115(4):760-9. PubMed ID: 19127559 [Abstract] [Full Text] [Related]
24. The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease. Woods MO, Younghusband HB, Parfrey PS, Gallinger S, McLaughlin J, Dicks E, Stuckless S, Pollett A, Bapat B, Mrkonjic M, de la Chapelle A, Clendenning M, Thibodeau SN, Simms M, Dohey A, Williams P, Robb D, Searle C, Green JS, Green RC. Gut; 2010 Oct 15; 59(10):1369-77. PubMed ID: 20682701 [Abstract] [Full Text] [Related]
25. Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer. Bosse T, ter Haar NT, Seeber LM, v Diest PJ, Hes FJ, Vasen HF, Nout RA, Creutzberg CL, Morreau H, Smit VT. Mod Pathol; 2013 Nov 15; 26(11):1525-35. PubMed ID: 23702729 [Abstract] [Full Text] [Related]
26. Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing. Cushman-Vokoun AM, Stover DG, Zhao Z, Koehler EA, Berlin JD, Vnencak-Jones CL. Clin Colorectal Cancer; 2013 Sep 15; 12(3):168-78. PubMed ID: 23773459 [Abstract] [Full Text] [Related]
27. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Loughrey MB, Waring PM, Tan A, Trivett M, Kovalenko S, Beshay V, Young MA, McArthur G, Boussioutas A, Dobrovic A. Fam Cancer; 2007 Sep 15; 6(3):301-10. PubMed ID: 17453358 [Abstract] [Full Text] [Related]
28. Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features. Rosty C, Young JP, Walsh MD, Clendenning M, Walters RJ, Pearson S, Pavluk E, Nagler B, Pakenas D, Jass JR, Jenkins MA, Win AK, Southey MC, Parry S, Hopper JL, Giles GG, Williamson E, English DR, Buchanan DD. Mod Pathol; 2013 Jun 15; 26(6):825-34. PubMed ID: 23348904 [Abstract] [Full Text] [Related]
30. Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. Goel A, Xicola RM, Nguyen TP, Doyle BJ, Sohn VR, Bandipalliam P, Rozek LS, Reyes J, Cordero C, Balaguer F, Castells A, Jover R, Andreu M, Syngal S, Boland CR, Llor X. Gastroenterology; 2010 May 01; 138(5):1854-62. PubMed ID: 20102720 [Abstract] [Full Text] [Related]
31. Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions. Cocco E, Benhamida J, Middha S, Zehir A, Mullaney K, Shia J, Yaeger R, Zhang L, Wong D, Villafania L, Nafa K, Scaltriti M, Drilon A, Saltz L, Schram AM, Stadler ZK, Hyman DM, Benayed R, Ladanyi M, Hechtman JF. Cancer Res; 2019 Mar 15; 79(6):1047-1053. PubMed ID: 30643016 [Abstract] [Full Text] [Related]
32. BRAF/KRAS gene sequencing of sebaceous neoplasms after mismatch repair protein analysis. Cornejo KM, Hutchinson L, Deng A, Tomaszewicz K, Welch M, Lyle S, Dresser K, Cosar EF. Hum Pathol; 2014 Jun 15; 45(6):1213-20. PubMed ID: 24767862 [Abstract] [Full Text] [Related]
33. MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes. Donehower LA, Creighton CJ, Schultz N, Shinbrot E, Chang K, Gunaratne PH, Muzny D, Sander C, Hamilton SR, Gibbs RA, Wheeler D. J Pathol; 2013 Jan 15; 229(1):99-110. PubMed ID: 22899370 [Abstract] [Full Text] [Related]
34. BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumors. Lubomierski N, Plotz G, Wormek M, Engels K, Kriener S, Trojan J, Jungling B, Zeuzem S, Raedle J. Cancer; 2005 Sep 01; 104(5):952-61. PubMed ID: 16015629 [Abstract] [Full Text] [Related]
35. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features. Schiemann U, Müller-Koch Y, Gross M, Daum J, Lohse P, Baretton G, Muders M, Mussack T, Kopp R, Holinski-Feder E. Digestion; 2004 Sep 01; 69(3):166-76. PubMed ID: 15118395 [Abstract] [Full Text] [Related]
36. Use of multivariate analysis to suggest a new molecular classification of colorectal cancer. Domingo E, Ramamoorthy R, Oukrif D, Rosmarin D, Presz M, Wang H, Pulker H, Lockstone H, Hveem T, Cranston T, Danielsen H, Novelli M, Davidson B, Xu ZZ, Molloy P, Johnstone E, Holmes C, Midgley R, Kerr D, Sieber O, Tomlinson I. J Pathol; 2013 Feb 01; 229(3):441-8. PubMed ID: 23165447 [Abstract] [Full Text] [Related]
37. MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events. de Vogel S, Weijenberg MP, Herman JG, Wouters KA, de Goeij AF, van den Brandt PA, de Bruïne AP, van Engeland M. Ann Oncol; 2009 Jul 01; 20(7):1216-22. PubMed ID: 19164452 [Abstract] [Full Text] [Related]
38. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma. Suehiro Y, Wong CW, Chirieac LR, Kondo Y, Shen L, Webb CR, Chan YW, Chan AS, Chan TL, Wu TT, Rashid A, Hamanaka Y, Hinoda Y, Shannon RL, Wang X, Morris J, Issa JP, Yuen ST, Leung SY, Hamilton SR. Clin Cancer Res; 2008 May 01; 14(9):2560-9. PubMed ID: 18451217 [Abstract] [Full Text] [Related]
39. Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome. Tresallet C, Brouquet A, Julié C, Beauchet A, Vallot C, Ménégaux F, Mitry E, Radvanyi F, Malafosse R, Rougier P, Nordlinger B, Laurent-Puig P, Boileau C, Emile JF, Muti C, Penna C, Hofmann-Radvanyi H. Int J Cancer; 2012 Mar 15; 130(6):1367-77. PubMed ID: 21520036 [Abstract] [Full Text] [Related]
40. Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification. Parsons MT, Buchanan DD, Thompson B, Young JP, Spurdle AB. J Med Genet; 2012 Mar 15; 49(3):151-7. PubMed ID: 22368298 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]